Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Compound 7, or Raloxifene 6-Monomethyl Ether, is a derivative of Raloxifene that effectively inhibits estrogen receptor α. It also displays the inhibitory effects on MCF-7 cells, with an IC50 of 250 nM and a pIC50 of 6.6.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | Inquiry | $ 1,520.00 |
Description | Compound 7, or Raloxifene 6-Monomethyl Ether, is a derivative of Raloxifene that effectively inhibits estrogen receptor α. It also displays the inhibitory effects on MCF-7 cells, with an IC50 of 250 nM and a pIC50 of 6.6. |
In vitro | Raloxifene 6-Monomethyl Ether (Compound 7), a derivative of Raloxifene featuring a methoxy group at the C6 position, exhibits a low inhibitory concentration (IC50) value. This reduced efficacy is attributed to the disruption of the hydrogen bond network and unfavorable steric interactions[1]. |
Molecular Weight | 487.61 |
Formula | C29H29NO4S |
CAS No. | 178451-13-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Raloxifene 6-Monomethyl Ether 178451-13-3 Raloxifene 6Monomethyl Ether Raloxifene 6 Monomethyl Ether inhibitor inhibit